| Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial A Venditti, A Piciocchi, A Candoni, V Arena, R Palmieri, C Filì, AM Carella, ... Blood Advances 8 (16), 4410-4413, 2024 | 1 | 2024 |
| Local therapy in glioma: An evolving paradigm from history to horizons T Ius, T Somma, F Pasqualetti, J Berardinelli, F Vitulli, M Caccese, E Cella, ... Oncology Letters 28 (3), 440, 2024 | | 2024 |
| Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage A Canossi, A Aureli, T Del Beato, G Novelli, O Buonomo, P Rossi, ... Current Molecular Medicine 24 (7), 920-930, 2024 | | 2024 |
| Cd64 chimeric receptor and uses thereof S Ferrone, G Sconocchia, S Caratelli US Patent App. 18/272,168, 2024 | | 2024 |
| Langerhans cell histiocytosis: current advances in molecular pathogenesis T Sconocchia, J Foßelteder, G Sconocchia, A Reinisch Frontiers in Immunology 14, 1275085, 2023 | 7 | 2023 |
| Acute lymphoblastic leukemia immunotherapy treatment: now, next, and beyond A Aureli, B Marziani, A Venditti, T Sconocchia, G Sconocchia Cancers 15 (13), 3346, 2023 | 13 | 2023 |
| Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases V Tassinari, P La Rosa, E Guida, A Colopi, S Caratelli, F De Paolis, ... Mechanisms of ageing and development 212, 111807, 2023 | 11 | 2023 |
| Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment G Sconocchia, G Lanzilli, V Cesarini, DA Silvestris, K Rezvani, R Arriga, ... Life science alliance 5 (12), 2022 | 1 | 2022 |
| Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia R Palmieri, M Othus, GS Cheng, F Buccisano, G Paterno, L Maurillo, ... Haematologica 107 (11), 2752, 2022 | 1 | 2022 |
| Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid … G Pasqualone, E Buzzatti, R Palmieri, A Savi, MR Pascale, B Borsellino, ... Frontiers in Oncology 12, 970188, 2022 | 1 | 2022 |
| Glioma extracellular vesicles for precision medicine: Prognostic and theragnostic application HE Marei, A Althani, N Afifi, A Hasan, T Caceci, I Cifola, S Caratelli, ... Discover Oncology 13 (1), 49, 2022 | 14 | 2022 |
| Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms E Buzzatti, G Paterno, R Palmieri, F Esposito, MR Pascale, F Mallegni, ... Leukemia & Lymphoma 63 (7), 1754-1757, 2022 | 3 | 2022 |
| Discover Oncology HE Marei, A Althani, N Afifi, A Hasan, T Caceci, I Cifola, S Caratelli, ... | | 2022 |
| Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and Treatment G Sconocchia, G Lanzilli, V Cesarini, DA Silvestris, R Arriga, K Rezvani, ... bioRxiv, 2021.12. 22.473841, 2021 | | 2021 |
| Immunotherapy as a turning point in the treatment of acute myeloid leukemia A Aureli, B Marziani, T Sconocchia, MI Del Principe, E Buzzatti, ... Cancers 13 (24), 6246, 2021 | 15 | 2021 |
| Regulation of the immune system in health and disease by members of the bone morphogenetic protein family T Sconocchia, G Sconocchia Frontiers in immunology 12, 802346, 2021 | 24 | 2021 |
| Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial E Aricò, L Castiello, L Bracci, F Urbani, F Lombardo, I Bacigalupo, ... Trials 22, 1-4, 2021 | 5 | 2021 |
| Activation of peripheral blood mononuclear cells and leptin secretion: new potential role of interleukin-2 and high mobility group box (HMGB) 1 A Coppola, B Capuani, F Pacifici, D Pastore, R Arriga, A Bellia, ... International journal of molecular sciences 22 (15), 7988, 2021 | 11 | 2021 |
| MEN1112/OBT357, a first-in-class humanized de-fucosylated monoclonal antibody targeting CD157 positive cells in acute myeloid leukemia and myelodysplastic syndrome C Carrisi, D Bellarosa, D Bisignano, A Venditti, F Buccisano, ... Cancer Research 81 (13_Supplement), 1170-1170, 2021 | | 2021 |
| EGFR+ Glioblastoma Stem Cells Targeting by CD16158V-Chimeric Receptor T Cells and Cetuximab C Cenciarelli, S Caratelli, R Arriga, G Lanzilli, A Ottaviani, T Sconocchia, ... J. Res 1, 24-35, 2021 | 1 | 2021 |
